Meta-Analysis
Copyright ©The Author(s) 2024.
World J Clin Cases. Aug 6, 2024; 12(22): 5083-5093
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.5083
Table 1 Basic features included in the literature
Ref.
Sample
Literature type
Random ratio
Intervention measures
Main outcome measures
Needle retention time
Treatment frequency
Course of treatment
Main conclusion
Chen and He[38] (2021) 90RCT1:1Treatment groupControl groupVAS30 minOnce a day4 wk+
Chi et al[39] (2021) 88RCT1:1AcupunctureCarbamazepineVAS/adverse event 20 minOnce a day1 mo+
Niu[40] (2021) 63RCT1:1AcupunctureCarbamazepineVAS/adverse event 30 minOnce a day30 d+
Qin[41] (2021) 62RCT1:1AcupunctureCarbamazepineVAS20 minOnce a day1 mo+
Wang and Zeng[42] (2021) 100RCT1:1AcupunctureCarbamazepineVAS30 minOnce a day30 d+
Wang[43] (2020)60RCT1:1AcupunctureCarbamazepineVAS20 minOnce a day3 mo+
Ta[44] (2020) 82RCT1:1AcupunctureCarbamazepineVAS30 minOnce a day30 wk+
Zhang et al[45] (2019)62RCT1:1AcupunctureCarbamazepineVAS30 minOnce a day90 d+
Hao et al[46] (2019)80RCT1:1AcupunctureCarbamazepineVAS/adverse event -Once a day-+
Wu et al[47] (2019) 100RCT1:1AcupunctureCarbamazepineVAS/adverse event 40 minOnce a day4 wk+
Xu and Wang[48] (2019)84RCT1:1AcupunctureCarbamazepineVAS/adverse event 20 minOnce a day4 wk+
Mu[49] (2019) 80RCT1:1AcupunctureCarbamazepineVAS20 minOnce a day30 d+
Wu and Sun[50] (2019) 60RCT1:1AcupunctureCarbamazepineVAS30 minOnce a day4 wk+
Liu and Liu[51] (2019) 40RCT1:1AcupunctureCarbamazepineVAS30 minOnce a day30 d+
Wang[52] (2019) 60RCT1:1AcupunctureCarbamazepineVAS30 minOnce a day30 d-
Si[53] (2018)120RCT1:1AcupunctureCarbamazepineVAS30 minOnce a day30 d+